Cargando…
Eicosapentaenoic and docosahexaenoic acid supplementation and inflammatory gene expression in the duodenum of obese patients with type 2 diabetes
BACKGROUND: The extent to which long-chain omega-3 polyunsaturated fatty acids (LCn-3PUFA) from fish oil such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) exert their anti-inflammatory effects by down-regulating intestinal inflammation in humans is unknown. We investigated the impac...
Autores principales: | Labonté, Marie-Ève, Couture, Patrick, Tremblay, André J, Hogue, Jean-Charles, Lemelin, Valéry, Lamarche, Benoît |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718629/ https://www.ncbi.nlm.nih.gov/pubmed/23855973 http://dx.doi.org/10.1186/1475-2891-12-98 |
Ejemplares similares
-
Genetic risk prediction of the plasma triglyceride response to independent supplementations with eicosapentaenoic and docosahexaenoic acids: the ComparED Study
por: Vallée Marcotte, Bastien, et al.
Publicado: (2020) -
n-3 Polyunsaturated Fatty Acid Supplementation Has No Effect on Postprandial Triglyceride-Rich Lipoprotein Kinetics in Men with Type 2 Diabetes
por: Tremblay, André J., et al.
Publicado: (2016) -
Evaluation of iTRAQ and SWATH-MS for the Quantification of Proteins Associated with Insulin Resistance in Human Duodenal Biopsy Samples
por: Bourassa, Sylvie, et al.
Publicado: (2015) -
Distinguishing Health Benefits of Eicosapentaenoic and Docosahexaenoic Acids
por: Russell, Fraser D., et al.
Publicado: (2012) -
Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation
por: Borja-Magno, Angélica, et al.
Publicado: (2023)